Finance

Lists
Q3 2026 earnings • released • EPS miss -2.34% • Revenue miss -6.77%
See results
PNVL3:BVMF
Dimed SA Distribuidora de Medicamentos
R$10.90
-1.54%
(-0.17) 1D
Nov 10, 3:47:57 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PNVL3...
Open
R$11.15
High
R$11.17
Low
R$10.85
Mkt. cap
1.64B
Avg. vol.
1.53M
Volume
450.10K
Dividend
3.66%
Quarterly dividend
R$0.10
Ex-dividend date
Apr 30, 2014
P/E ratio
11.95
52-wk high
R$16.29
52-wk low
R$8.67
EPS
R$0.91
Shares outstanding
150.38M
No. of employees
11K
Open
R$11.15
High
R$11.17
Low
R$10.85
Mkt. cap
1.64B
Avg. vol.
1.53M
Volume
450.10K
Dividend
3.66%
Quarterly dividend
R$0.10
Ex-dividend date
Apr 30, 2014
P/E ratio
11.95
52-wk high
R$16.29
52-wk low
R$8.67
EPS
R$0.91
Shares outstanding
150.38M
No. of employees
11K
News stories
From web sources and news partners
About Dimed SA Distribuidora de Medicamentos
CEO-
Employees11.4K
Founded1920
Headquarters-
SectorConsumer Staples
IndustryDrug
Websitegrupopanvel.com.br
Last report
Nov 6, 2026
Fiscal period
Q3 2026
R$0.31 / R$0.32
-2.34%miss
Revenue / Est. (BRL)
1.57B / 1.69B
-6.77%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.37B
1.57B
1.45B
1.51B
Cost of goods sold
934.42M
1.03B
895.86M
1.01B
Cost of revenue
934.42M
1.03B
895.86M
1.01B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374.10M
447.70M
398.26M
434.04M
Operating expense
369.24M
460.93M
486.17M
438.84M
Total operating expenses
1.30B
1.49B
1.38B
1.45B
Operating income
70.33M
78.49M
67.63M
63.84M
Other non operating income
-4.39M
-6.17M
-3.34M
-875.00K
EBT including unusual items
41.77M
46.89M
37.18M
35.36M
EBT excluding unusual items
42.82M
48.39M
36.64M
32.72M
Income tax expense
10.47M
4.14M
3.94M
4.99M
Effective tax rate
25.07%
8.83%
10.61%
14.11%
Other operating expenses
-4.86M
13.23M
87.91M
4.79M
Net income
31.30M
42.75M
33.23M
30.37M
Net profit margin
2.28%
2.73%
2.29%
2.01%
Earnings per share
-
-
-
0.26
Interest and investment income
10.22M
14.55M
12.28M
8.51M
Interest expense
-33.34M
-38.48M
-39.93M
-38.76M
Net interest expenses
-23.12M
-23.93M
-27.65M
-30.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
87.05M
95.46M
84.75M
81.22M
Gain or loss from assets sale
-
-
-2.92M
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps